Literature DB >> 23456848

Can we extend thrombolysis indications for acute ischaemic stroke? The IST-3 study.

Marta Del Medico1, Antonella Bonura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23456848     DOI： 10.1007/s11739-012-0899-1

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  3 in total

1.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Stroke       Date:  2007-04-12       Impact factor: 7.914

Review 2.  Thrombolysis for acute ischaemic stroke.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory J Del Zoppo
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

3.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321
  3 in total
  2 in total

1.  Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane revision: cons.

Authors:  Giorgio Costantino; Gian Marco Podda; Mattia Bonzi; Rodolfo Sbrojavacca
Journal:  Intern Emerg Med       Date:  2013-08-23       Impact factor: 3.397

2.  Italian guidelines on thrombolysis indications in ischaemic stroke have been revised after IST 3 trial and Cochrane Review: PROS.

Authors:  Stefano Ricci; Silvia Cenciarelli; Tatiana Mazzoli
Journal:  Intern Emerg Med       Date:  2013-08-23       Impact factor: 3.397
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.